硬斑病性秃发研究进展

doi:10.35541/cjd.20220829

Abstract

Abstract: 【Abstract】 Morphea alopecia is a rare secondary cicatricial alopecia, often caused by linear scleroderma of the scalp. When the hair loss becomes the only symptom of morphea, it is easily confused with other localized alopecia. The diagnosis of morphea alopecia depends on histopathologic and dermoscopic examinations. In order to improve the understanding of morphea alopecia among clinicians, this review summarizes research progress in its pathogenesis, clinical and pathological characteristics, diagnosis and treatment.

Key words: Alopecia, Scleroderma, localized, Morphea alopecia, Cicatricial alopecia, Morphea, Linear scleroderma

Tao Qiuwei, Chen Qitao, Shao Guanghui, Li Yuqian, Zhu Qilin, Zhu Jing, Li Zhongming, Du Xufeng. Morphea alopecia[J]. Chinese Journal of Dermatology,2024,e20220829. doi:10.35541/cjd.20220829

References ［51］

［1］	Snarskaya ES, Vasileva KD. Localized scleroderma: actual insights and new biomarkers［J］. Int J Dermatol, 2022,61（6）:667⁃674. doi: 10.1111/ijd.15811.
［2］	Glaser DH, Schutt C, VonVille HM, et al. Linear scleroderma of the head ⁃ updates in management of Parry Romberg syndrome and en coup de sabre: a rapid scoping review across subspecialties［J］. Eur J Rheumatol, 2020,7（Suppl1）:S48⁃S57. doi: 10.5152/eurjrheum.2019.19183.
［3］	Chiu YE, Shmuylovich L, Kiguradze T, et al. Body site distribution of pediatric⁃onset morphea and association with extracutaneous manifestations［J］. J Am Acad Dermatol, 2021,85（1）:38⁃45. doi: 10.1016/j.jaad.2021.03.017.
［4］	Zaaroura H, Pope E, Laxer RM, et al. Reversible alopecia in en coup de sabre morphea［J］. Pediatr Dermatol, 2021,38（6）:1532⁃1534. doi: 10.1111/pde.14827.
［5］	Pierre⁃Louis M, Sperling LC, Wilke MS, et al. Distinctive histopathologic findings in linear morphea （en coup de sabre） alopecia［J］. J Cutan Pathol, 2013,40（6）:580⁃584. doi: 10.1111/cup.12124.
［6］	Finner AM, Otberg N, Shapiro J. Secondary cicatricial and other permanent alopecias［J］. Dermatol Ther, 2008,21（4）:279⁃294. doi: 10.1111/j.1529⁃8019.2008.00210.x.
［7］	Goh C, Biswas A, Goldberg LJ. Alopecia with perineural lymphocytes: a clue to linear scleroderma en coup de sabre［J］. J Cutan Pathol, 2012,39（5）:518⁃520. doi: 10.1111/j.1600⁃0560. 2012.01889.x.
［8］	de Marsillac PF, Cortez de Almeida RF, Machado CJ, et al. Clinical, epidemiological, trichoscopic and histopathological features of linear morphea on the scalp［J］. J Eur Acad Dermatol Venereol, 2022,36（11）:e892⁃e895. doi: 10.1111/jdv.18323.
［9］	Asano Y, Ihn H, Tamaki K. An unusual manifestation of linear scleroderma ′en coup de sabre′ on the vertex and frontoparietal regions［J］. Clin Exp Dermatol, 2007,32（6）:758⁃759. doi: 10. 1111/j.1365⁃2230.2007.02521.x.
［10］	Saceda⁃Corralo D, Tosti A. Trichoscopic features of linear morphea on the scalp［J］. Skin Appendage Disord, 2018,4（1）:31⁃33. doi: 10.1159/000478022.
［11］	Vázquez Sánchez M, Fuentelsaz Del Barrio MV, Conejero Del Mazo R, et al. Linear morphea in saber coup: about a case［J］. Arch Argent Pediatr, 2022,120（2）:e75⁃e79. doi: 10.5546/aap. 2022.e75.
［12］	王友力, 罗宏宾, 曹毅, 等. 枕部线状硬皮病1例［J］. 现代中西医结合杂志, 2009,18（27）:3364⁃3365. doi: 10.3969/j.issn.1008⁃8849.2009.27.074.
［13］	Wenzel D, Haddadi NS, Afshari K, et al. Upcoming treatments for morphea［J］. Immun Inflamm Dis, 2021,9（4）:1101⁃1145. doi: 10.1002/iid3.475.
［14］	Hixon AM, Christensen E, Hamilton R, et al. Epilepsy in Parry⁃Romberg syndrome and linear scleroderma en coup de sabre: case series and systematic review including 140 patients［J］. Epilepsy Behav, 2021,121（Pt A）:108068. doi: 10.1016/j.yebeh. 2021.108068.
［15］	Polcari I, Moon A, Mathes EF, et al. Headaches as a presenting symptom of linear morphea en coup de sabre［J］. Pediatrics, 2014,134（6）:e1715⁃e1719. doi: 10.1542/peds.2014⁃0019.
［16］	Oh YH, Lee SH. Frontal linear scleroderma （en coup de sabre）: a case report［J］. Cleft Palate Craniofac J, 2022,59（4）:538⁃542. doi: 10.1177/10556656211013168.
［17］	Creadore A, Watchmaker J, Maymone M, et al. Cosmetic treatment in patients with autoimmune connective tissue diseases: best practices for patients with morphea/systemic sclerosis［J］. J Am Acad Dermatol, 2020,83（2）:315⁃341. doi: 10.1016/j.jaad. 2019.12.081.
［18］	刘金娟, 刘彤. Wnt2、Wnt3a和β⁃catenin在硬皮病患者皮损中的作用［J］. 南方医科大学学报, 2012,32（12）:1781⁃1786. doi: 10.3969/j.issn.1673⁃4254.2012.12.021.
［19］	Imhof RL, Cantwell HM, Proffer SL, et al. The spectrum of pediatric scarring alopecia: a retrospective review of 27 patients seen at Mayo clinic［J］. Pediatr Dermatol, 2021,38（3）:580⁃584. doi: 10.1111/pde.14543.
［20］	Hordinsky M. Scarring alopecia: diagnosis and new treatment options［J］. Dermatol Clin, 2021,39（3）:383⁃388. doi: 10.1016/j.det.2021.05.001.
［21］	Villablanca S, Fischer C, García⁃García SC, et al. Primary scarring alopecia: clinical⁃pathological review of 72 cases and review of the literature［J］. Skin Appendage Disord, 2017,3（3）:132⁃143. doi: 10.1159/000467395.
［22］	Toyama S, Sato S, Asano Y. Localized scleroderma histologically characterized by liquefaction degeneration and upper dermis fibrosis: a possible association with chemotherapy［J］. Clin Exp Dermatol, 2020,45（5）:632⁃634. doi: 10.1111/ced.14216.
［23］	Walker D, Susa JS, Currimbhoy S, et al. Histopathological changes in morphea and their clinical correlates: results from the Morphea in Adults and Children Cohort V［J］. J Am Acad Dermatol, 2017,76（6）:1124⁃1130. doi: 10.1016/j.jaad.2016.12. 020.
［24］	Sonthalia S, Agrawal M, Sharma P, et al. Linear patch of alopecia in a child: trichoscopy reveals the actual diagnosis［J］. Skin Appendage Disord, 2019,5（6）:409⁃412. doi: 10.1159/000500096.
［25］	Saceda⁃Corralo D, Nusbaum AG, Romanelli P, et al. A case of circumscribed scalp morphea with perineural lymphocytes on pathology［J］. Skin Appendage Disord, 2017,3（4）:175⁃178. doi: 10.1159/000471855.
［26］	Zhang S, Zhu QL, Xiao MS, et al. The value of dermoscopy and high⁃frequency ultrasound in staging morphea［J］. J Dermatol, 2023,50（4）:511⁃517. doi: 10.1111/1346⁃8138.16648.
［27］	Meng L, Wang Q. Neuroimaging findings of linear scleroderma of the head and face: a case report［J］. J Int Med Res, 2022,50（1）:3000605 211066002. doi: 10.1177/03000605211066002.
［28］	Alwash N, Dinani N, Felton J. A case of multiple cerebral cavernomas associated with en coup de sabre scleroderma［J］. Pediatr Dermatol, 2020,37（1）:237⁃238. doi: 10.1111/pde.14052.
［29］	Martins R, Quintas S, Coelho J, et al. Extensive linear scleroderma en coup de sabre with exertion⁃induced hemiplegic migraine［J］. Mult Scler Relat Disord, 2020,37:101457. doi: 10.1016/j.msard.2019.101457.
［30］	Seese RR, Glaser D, Furtado A, et al. Unilateral neuroimaging findings in pediatric craniofacial scleroderma: Parry⁃Romberg syndrome and en coup de sabre［J］. J Child Neurol, 2020,35（11）:753⁃762. doi: 10.1177/0883073820931253.
［31］	Jindal AK, Handa S, Loganathan SK, et al. Juvenile localized scleroderma: a single⁃centre experience from India［J］. J Eur Acad Dermatol Venereol, 2023,37（3）:598⁃604. doi: 10.1111/jdv.18765.
［32］	Kim J, Chung KB, Lee YI, et al. Clinical characteristics and histopathologic changes of morphea: a single⁃center, retrospective study of 137 patients［J］. J Am Acad Dermatol, 2021,85（1）:105⁃113. doi: 10.1016/j.jaad.2020.11.006.
［33］	Romagnuolo M, Moltrasio C, Barbareschi M, et al. Circumscribed morphea of the scalp: an entity to be considered in the differential diagnosis of cicatricial alopecia［J］. Skin Appendage Disord, 2022,8（6）:500⁃503. doi: 10.1159/000525355.
［34］	Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options［J］. Clin Exp Med, 2021,21（2）:215⁃230. doi: 10.1007/s10238⁃020⁃00673⁃w.
［35］	Concha J, Werth VP. Alopecias in lupus erythematosus［J］. Lupus Sci Med, 2018,5（1）:e000291. doi: 10.1136/lupus⁃2018⁃000291.
［36］	Cantwell HM, Wieland CN, Proffer SL, et al. Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients［J］. Int J Dermatol, 2021,60（4）:482⁃488. doi: 10.1111/ijd.15285.
［37］	Peña⁃Romero AG, García⁃Romero MT. Diagnosis and manage⁃ment of linear scleroderma in children［J］. Curr Opin Pediatr, 2019,31（4）:482⁃490. doi: 10.1097/MOP.0000000000000785.
［38］	Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre （linear morphea subtype）［J］. J Dermatolog Treat, 2018,29（2）:197⁃199. doi: 10.1080/09546634. 2017.1341615.
［39］	Fadanelli G, Agazzi A, Vittadello F, et al. Methotrexate in linear scleroderma: long⁃term efficacy in fifty children from a single pediatric rheumatology center［J］. Arthritis Care Res （Hoboken）, 2021,73（9）:1259⁃1263. doi: 10.1002/acr.24260.
［40］	Weibel L, Theiler M, Howell KJ, et al. Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma （morphoea） to steroids and methotrexate using multi⁃modal imaging［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:1609⁃1616. doi: 10.1111/jdv.16308.
［41］	Khan MA, Shaw L, Eleftheriou D, et al. Radiologic improvement after early medical intervention in localised facial morphea［J］. Pediatr Dermatol, 2016,33（2）:e95⁃e98. doi: 10.1111/pde.12799.
［42］	Martini G, Saggioro L, Culpo R, et al. Mycophenolate mofetil for methotrexate⁃resistant juvenile localized scleroderma［J］. Rheumatology （Oxford）, 2021,60（3）:1387⁃1391. doi: 10.1093/rheumatology/keaa392.
［43］	McGaugh S, Kallis P, De Benedetto A, et al. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: a literature review［J］. Dermatol Ther, 2022,35（6）:e15437. doi: 10.1111/dth.15437.
［44］	Furuhashi T, Torii K, Ikumi K, et al. Ultraviolet A1 phototherapy for the treatment of localized scleroderma［J］. J Dermatol, 2020,47（7）:792⁃795. doi: 10.1111/1346⁃8138.15368.
［45］	Kato H, Shintani Y, Yamaguchi Y, et al. A surgical approach for stable lesions of linear scleroderma［J］. Kaohsiung J Med Sci, 2010,26（11）:621⁃623. doi: 10.1016/S1607⁃551X（10）70095⁃4.
［46］	Skorochod R, Nesher G, Gronovich Y. Management options for linear scleroderma （"en coup de sabre"）［J］. Dermatol Surg, 2022,48（10）:1038⁃1045. doi: 10.1097/DSS.0000000000003539.
［47］	Ayoub R, Saba SC. Treatment of linear scleroderma "en coup de sabre" with single⁃stage autologous fat grafting: a case report and review of the literature［J］. J Cosmet Dermatol, 2021,20（1）:285⁃289. doi: 10.1111/jocd.13490.
［48］	L′Orphelin JM, Garmi R, Labbé D, et al. Autologous fat grafting for the treatment of sclerotic lesions and scars［J］. Ann Dermatol Venereol, 2021,148（1）:40⁃44. doi: 10.1016/j.annder.2020.06.022.
［49］	Wang HC, Sun ET, Zhao RC, et al. Adipose⁃derived stem cells attenuate skin fibrosis and improve fat retention of a localized scleroderma mouse model［J］. Plast Reconstr Surg, 2023,151（1）:97⁃107. doi: 10.1097/PRS.0000000000009796.
［50］	Langridge BJ, Jeon FHK, Almadori A, et al. Autologous lipotransfer can improve the outcomes of localised scleroderma［J］. Clin Exp Rheumatol, 2021,Suppl 131（4）:159. doi: 10.55563/ clinexprheumatol/uczb6s.
［51］	戴叶芹, 许爱娥. 微小毛胚移植辅助治疗头皮线状硬皮病一例［J］. 中华皮肤科杂志, 2014,47（11）:826⁃827. doi: 10.3760/cma.j.issn.0412⁃4030.2014.011.019.

[1]	Zhang Shuo, Zhang Wei, Xu Dan. Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment [J]. Chinese Journal of Dermatology, 2024, 57(8): 761-764.
[2]	Chen Yuhong, Lyu Zhongfa. Regulatory mechanisms underlying the hair cycle [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230226-e20230226.
[3]	Yang Jie, Liu Liping. Application of single-cell sequencing in the hair research [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230292-e20230292.
[4]	Wei Ran, Li Qinfeng. Novel targeted drugs for the treatment of pediatric alopecia areata [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230660-e20230660.
[5]	Jiang Jiayi, Wang Daguang. Diagnosis and treatment of non-infectious inflammatory disorders of the nail apparatus [J]. Chinese Journal of Dermatology, 2024, 57(12): 1153-1157.
[6]	Wang Lili, Yang Bin, Luo Ying. Correlations of the onset of androgenic alopecia with family history and serum dihydrotestosterone levels in 614 female patients [J]. Chinese Journal of Dermatology, 2024, 57(12): 1127-1129.
[7]	Pan Ting, Mu Yuzhu, Shi Xin, Chen Lingling. Upadacitinib for the successful treatment of an adolescent with severe alopecia areata complicated by atopic dermatitis [J]. Chinese Journal of Dermatology, 2024, 57(12): 1138-1140.
[8]	Wang Yuting, Yao Manxue, Zhou Naihui. Combined microneedling for the treatment of androgenetic alopecia [J]. Chinese Journal of Dermatology, 2024, 57(1): 82-84.
[9]	Liu Yuanxiang, Liang Yuan, Zhao Xinrong, Sun Yujuan, Ma Lin, Xu Zigang. Janus kinase inhibitors for the treatment of five children with severe alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 849-852.
[10]	Wang Yuqian, Qiao Jianjun, Fang Hong. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888.
[11]	Sun Xiaojie, Liu Yi. Anti-androgen drugs in the treatment of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(9): 882-885.
[12]	Wang Junxia, Guo Weinan, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao. Efficacy of autologous fat grafting in the treatment of 40 cases of stable linear scleroderma: a retrospective analysis [J]. Chinese Journal of Dermatology, 2023, 56(8): 762-765.
[13]	Shen Yuqing, Song Xiuzu. Ultraviolet and androgenetic alopecia [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210949-e20210949.
[14]	Sun Jiayi, Song Xiuzu. Autophagy in hair physiology and pathology [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220036-e20220036.
[15]	Zhang Li, Song Xiuzu. Role of vascular endothelial growth factor in androgenetic alopecia [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220240-e20220240.

Morphea alopecia

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［51］

Related Articles 15

Metrics

Comments

Recommended 10